Reach Fertility has an experienced research division solely dedicated to conducting clinical research trials. Our research has been published in leading fertility journals and contributed to advancements in the field of Reproductive Endocrinology. Clinical research trial participants may qualify to receive low-cost or no-cost fertility treatment.
Learn more about our current clinical trial below
Reach is currently seeking women to participate in a fertility research study to look at whether a new Progesterone preparation administered as an injection under the skin is safe and effective in supporting the implantation and early pregnancy following frozen euploid transfer (FET) in comparison to Crinone, a progesterone administered vaginally.
You may be eligible for the study if you:
- Have a euploid (normal) embryo from a previous IVF cycle or
if you are a candidate for FET
- Are between 35 to 42 years old
- Have a BMI of <38 kg/m2
- Have regular menstrual cycle of 24 to 38 days
- Do not have history of recurrent pregnancy loss (2 or more)
If you’re a candidate for the study, the study drugs and the genetic testing for the embryo will be provided at no cost to you. If you already have a frozen euploid embryo from a prior cycle that meets the study criteria you will receive up to $10,000 credit or discount that will be applied to your IVF costs if you undergo FET.
To learn more information and if you may qualify for the study:
Please contact email@example.com
You must complete a new patient consultation if you are not already an established Reach patient.
Contact our team to get started at 704-343-4444
FOR MORE INFORMATION ABOUT ENROLLING IN A CLINICAL RESEARCH TRIAL, PLEASE SUBMIT THE FORM BELOW.